0.62EUR
758.30 MEUR
8.88 BEUR
1.65 B
About DAIICHI SANKYO CO. LTD
Sector
CEO
Sunao Manabe
Headquarters
Tokyo
Website
Employees (FY)
17.44 K
Founded
2005
ISIN
JP3475350009
FIGI
BBG000DXRMJ4
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange DAIICHI SANKYO CO. LTD stocks are traded under the ticker D4S.
DAIICHI SANKYO CO. LTD is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
D4S earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.13 EUR resulting in a 2.95% surprise. The estimated earnings for the next quarter are 0.11 EUR per share. See more details about DAIICHI SANKYO CO. LTD earnings.
DAIICHI SANKYO CO. LTD revenue for the last quarter amounts to 2.38 B EUR despite the estimated figure of 2.31 B EUR. In the next quarter revenue is expected to reach 2.62 B EUR.
Yes, you can track DAIICHI SANKYO CO. LTD financials in yearly and quarterly reports right on TradingView.
D4S net income for the last quarter is 427.37 M EUR, while the quarter before that showed 253.18 M EUR of net income which accounts for 68.80% change. Track more DAIICHI SANKYO CO. LTD financial stats to get the full picture.
DAIICHI SANKYO CO. LTD dividend yield was 0.62% in 2022, and payout ratio reached 52.67%. The year before the numbers were 1.01% and 77.27% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, D4S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAIICHI SANKYO CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 17.44 K employees. See our rating of the largest employees — is DAIICHI SANKYO CO. LTD on this list?
We've gathered analysts' opinions on DAIICHI SANKYO CO. LTD future price: according to them, D4S price has a max estimate of 38.19 EUR and a min estimate of 25.46 EUR. Read a more detailed DAIICHI SANKYO CO. LTD forecast: see what analysts think of DAIICHI SANKYO CO. LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAIICHI SANKYO CO. LTD EBITDA is 1.38 B EUR, and current EBITDA margin is 14.83%. See more stats in DAIICHI SANKYO CO. LTD financial statements.